Measuring intolerance to mutation in human genetics.
William J BeldenJeremy J BergHakhamanesh MostafaviGuy SellaMolly PrzeworskiPublished in: Nature genetics (2019)
In numerous applications, from working with animal models to mapping the genetic basis of human disease susceptibility, knowing whether a single disrupting mutation in a gene is likely to be deleterious is useful. With this goal in mind, a number of measures have been developed to identify genes in which protein-truncating variants (PTVs), or other types of mutations, are absent or kept at very low frequency in large population samples-genes that appear 'intolerant' to mutation. One measure in particular, the probability of being loss-of-function intolerant (pLI), has been widely adopted. This measure was designed to classify genes into three categories, null, recessive and haploinsufficient, on the basis of the contrast between observed and expected numbers of PTVs. Such population-genetic approaches can be useful in many applications. As we clarify, however, they reflect the strength of selection acting on heterozygotes and not dominance or haploinsufficiency.
Keyphrases
- genome wide
- copy number
- genome wide identification
- endothelial cells
- dna methylation
- induced pluripotent stem cells
- genome wide analysis
- bioinformatics analysis
- pluripotent stem cells
- magnetic resonance
- high resolution
- intellectual disability
- transcription factor
- computed tomography
- amino acid
- protein protein
- mass spectrometry
- duchenne muscular dystrophy